Serveur d'exploration sur le patient édenté (maquette)

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Use of Oral Chroma™ in the assessment of volatile sulfur compounds in patients with fixed protheses.

Identifieur interne : 000E01 ( PubMed/Checkpoint ); précédent : 000E00; suivant : 000E02

Use of Oral Chroma™ in the assessment of volatile sulfur compounds in patients with fixed protheses.

Auteurs : B. Sinjari [Italie] ; G. Murmura ; S. Caputi ; L. Ricci ; G. Varvara ; A. Scarano

Source :

RBID : pubmed:24067465

Descripteurs français

English descriptors

Abstract

Prosthetic rehabilitation improves the patient's quality of life and oral health. The purpose of the present study was to assess the production of volatile sulfur compounds (VSCs) using Oral Chroma™ in patients wearing provisional and permanent fixed prosthesis, who were treated or not, with supportive non-surgical periodontal therapy. A total of 10 healthy patients not affected by periodontal disease and who needed the restoration of at least two edentulous single sites were included in the present study. Registrations of VSCs were carried out with a Gas Chromatograph OralChroma™ (Oral Chroma™, Abimedical, Abilit Corp., Osaka, Japan) one month after placement of the provisional restoration (group 1) and one month after placement of the final restoration (group 3). After each measurement, professional oral hygiene was carried out both on patients with provisional (group 2) and permanent prostheses (group 4) and VSC values were registered. The results showed that there were no statistical significant differences in the VSC quantity between groups with temporary or permanent prostheses. Meanwhile, statistically significant differences were found in VCS values between groups before and after the professional health care session (p less than 0.05). Also it was observed that dimethyl sulphide (CH3)2S was present in all the study groups. The present preliminary study suggests that OralChroma™ produce a comprehensive assessment of VSC in the clinical diagnosis of halitosis and that professional oral hygiene seems to influence VSC production. However, further clinical long-term studies with a larger sample size are necessary for a better understanding of halitosis manifestation in patients wearing provisional and permanent fixed prosthesis.

DOI: 10.1177/039463201302600312
PubMed: 24067465


Affiliations:


Links toward previous steps (curation, corpus...)


Links to Exploration step

pubmed:24067465

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Use of Oral Chroma™ in the assessment of volatile sulfur compounds in patients with fixed protheses.</title>
<author>
<name sortKey="Sinjari, B" sort="Sinjari, B" uniqKey="Sinjari B" first="B" last="Sinjari">B. Sinjari</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Medical, Oral and Biotechnological Sciences, University of Chieti-Pescara, Italy.</nlm:affiliation>
<country xml:lang="fr">Italie</country>
<wicri:regionArea>Department of Medical, Oral and Biotechnological Sciences, University of Chieti-Pescara</wicri:regionArea>
<wicri:noRegion>University of Chieti-Pescara</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Murmura, G" sort="Murmura, G" uniqKey="Murmura G" first="G" last="Murmura">G. Murmura</name>
</author>
<author>
<name sortKey="Caputi, S" sort="Caputi, S" uniqKey="Caputi S" first="S" last="Caputi">S. Caputi</name>
</author>
<author>
<name sortKey="Ricci, L" sort="Ricci, L" uniqKey="Ricci L" first="L" last="Ricci">L. Ricci</name>
</author>
<author>
<name sortKey="Varvara, G" sort="Varvara, G" uniqKey="Varvara G" first="G" last="Varvara">G. Varvara</name>
</author>
<author>
<name sortKey="Scarano, A" sort="Scarano, A" uniqKey="Scarano A" first="A" last="Scarano">A. Scarano</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="????">
<PubDate>
<MedlineDate>2013 Jul-Sep</MedlineDate>
</PubDate>
</date>
<idno type="RBID">pubmed:24067465</idno>
<idno type="pmid">24067465</idno>
<idno type="doi">10.1177/039463201302600312</idno>
<idno type="wicri:Area/PubMed/Corpus">000451</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000451</idno>
<idno type="wicri:Area/PubMed/Curation">000451</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000451</idno>
<idno type="wicri:Area/PubMed/Checkpoint">000451</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000451</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Use of Oral Chroma™ in the assessment of volatile sulfur compounds in patients with fixed protheses.</title>
<author>
<name sortKey="Sinjari, B" sort="Sinjari, B" uniqKey="Sinjari B" first="B" last="Sinjari">B. Sinjari</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Medical, Oral and Biotechnological Sciences, University of Chieti-Pescara, Italy.</nlm:affiliation>
<country xml:lang="fr">Italie</country>
<wicri:regionArea>Department of Medical, Oral and Biotechnological Sciences, University of Chieti-Pescara</wicri:regionArea>
<wicri:noRegion>University of Chieti-Pescara</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Murmura, G" sort="Murmura, G" uniqKey="Murmura G" first="G" last="Murmura">G. Murmura</name>
</author>
<author>
<name sortKey="Caputi, S" sort="Caputi, S" uniqKey="Caputi S" first="S" last="Caputi">S. Caputi</name>
</author>
<author>
<name sortKey="Ricci, L" sort="Ricci, L" uniqKey="Ricci L" first="L" last="Ricci">L. Ricci</name>
</author>
<author>
<name sortKey="Varvara, G" sort="Varvara, G" uniqKey="Varvara G" first="G" last="Varvara">G. Varvara</name>
</author>
<author>
<name sortKey="Scarano, A" sort="Scarano, A" uniqKey="Scarano A" first="A" last="Scarano">A. Scarano</name>
</author>
</analytic>
<series>
<title level="j">International journal of immunopathology and pharmacology</title>
<idno type="ISSN">0394-6320</idno>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Adolescent</term>
<term>Adult</term>
<term>Bacteria (metabolism)</term>
<term>Breath Tests</term>
<term>Chromatography, Gas</term>
<term>Dental Prophylaxis</term>
<term>Dental Restoration, Permanent (adverse effects)</term>
<term>Dental Restoration, Temporary (adverse effects)</term>
<term>Female</term>
<term>Halitosis (diagnosis)</term>
<term>Halitosis (microbiology)</term>
<term>Halitosis (prevention & control)</term>
<term>Humans</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Oral Hygiene</term>
<term>Predictive Value of Tests</term>
<term>Prosthesis-Related Infections (diagnosis)</term>
<term>Prosthesis-Related Infections (microbiology)</term>
<term>Prosthesis-Related Infections (prevention & control)</term>
<term>Sulfur Compounds (metabolism)</term>
<term>Time Factors</term>
<term>Treatment Outcome</term>
<term>Volatilization</term>
<term>Young Adult</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr">
<term>Adolescent</term>
<term>Adulte</term>
<term>Adulte d'âge moyen</term>
<term>Bactéries (métabolisme)</term>
<term>Chromatographie en phase gazeuse</term>
<term>Composés du soufre (métabolisme)</term>
<term>Facteurs temps</term>
<term>Femelle</term>
<term>Halitose ()</term>
<term>Halitose (diagnostic)</term>
<term>Halitose (microbiologie)</term>
<term>Humains</term>
<term>Hygiène buccodentaire</term>
<term>Infections dues aux prothèses ()</term>
<term>Infections dues aux prothèses (diagnostic)</term>
<term>Infections dues aux prothèses (microbiologie)</term>
<term>Jeune adulte</term>
<term>Mâle</term>
<term>Prophylaxie dentaire</term>
<term>Restaurations dentaires permanentes (effets indésirables)</term>
<term>Restaurations dentaires temporaires (effets indésirables)</term>
<term>Résultat thérapeutique</term>
<term>Tests d'analyse de l'haleine</term>
<term>Valeur prédictive des tests</term>
<term>Volatilisation</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="metabolism" xml:lang="en">
<term>Sulfur Compounds</term>
</keywords>
<keywords scheme="MESH" qualifier="adverse effects" xml:lang="en">
<term>Dental Restoration, Permanent</term>
<term>Dental Restoration, Temporary</term>
</keywords>
<keywords scheme="MESH" qualifier="diagnosis" xml:lang="en">
<term>Halitosis</term>
<term>Prosthesis-Related Infections</term>
</keywords>
<keywords scheme="MESH" qualifier="diagnostic" xml:lang="fr">
<term>Halitose</term>
<term>Infections dues aux prothèses</term>
</keywords>
<keywords scheme="MESH" qualifier="effets indésirables" xml:lang="fr">
<term>Restaurations dentaires permanentes</term>
<term>Restaurations dentaires temporaires</term>
</keywords>
<keywords scheme="MESH" qualifier="metabolism" xml:lang="en">
<term>Bacteria</term>
</keywords>
<keywords scheme="MESH" qualifier="microbiologie" xml:lang="fr">
<term>Halitose</term>
<term>Infections dues aux prothèses</term>
</keywords>
<keywords scheme="MESH" qualifier="microbiology" xml:lang="en">
<term>Halitosis</term>
<term>Prosthesis-Related Infections</term>
</keywords>
<keywords scheme="MESH" qualifier="métabolisme" xml:lang="fr">
<term>Bactéries</term>
<term>Composés du soufre</term>
</keywords>
<keywords scheme="MESH" qualifier="prevention & control" xml:lang="en">
<term>Halitosis</term>
<term>Prosthesis-Related Infections</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Adolescent</term>
<term>Adult</term>
<term>Breath Tests</term>
<term>Chromatography, Gas</term>
<term>Dental Prophylaxis</term>
<term>Female</term>
<term>Humans</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Oral Hygiene</term>
<term>Predictive Value of Tests</term>
<term>Time Factors</term>
<term>Treatment Outcome</term>
<term>Volatilization</term>
<term>Young Adult</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr">
<term>Adolescent</term>
<term>Adulte</term>
<term>Adulte d'âge moyen</term>
<term>Chromatographie en phase gazeuse</term>
<term>Facteurs temps</term>
<term>Femelle</term>
<term>Halitose</term>
<term>Humains</term>
<term>Hygiène buccodentaire</term>
<term>Infections dues aux prothèses</term>
<term>Jeune adulte</term>
<term>Mâle</term>
<term>Prophylaxie dentaire</term>
<term>Résultat thérapeutique</term>
<term>Tests d'analyse de l'haleine</term>
<term>Valeur prédictive des tests</term>
<term>Volatilisation</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Prosthetic rehabilitation improves the patient's quality of life and oral health. The purpose of the present study was to assess the production of volatile sulfur compounds (VSCs) using Oral Chroma™ in patients wearing provisional and permanent fixed prosthesis, who were treated or not, with supportive non-surgical periodontal therapy. A total of 10 healthy patients not affected by periodontal disease and who needed the restoration of at least two edentulous single sites were included in the present study. Registrations of VSCs were carried out with a Gas Chromatograph OralChroma™ (Oral Chroma™, Abimedical, Abilit Corp., Osaka, Japan) one month after placement of the provisional restoration (group 1) and one month after placement of the final restoration (group 3). After each measurement, professional oral hygiene was carried out both on patients with provisional (group 2) and permanent prostheses (group 4) and VSC values were registered. The results showed that there were no statistical significant differences in the VSC quantity between groups with temporary or permanent prostheses. Meanwhile, statistically significant differences were found in VCS values between groups before and after the professional health care session (p less than 0.05). Also it was observed that dimethyl sulphide (CH3)2S was present in all the study groups. The present preliminary study suggests that OralChroma™ produce a comprehensive assessment of VSC in the clinical diagnosis of halitosis and that professional oral hygiene seems to influence VSC production. However, further clinical long-term studies with a larger sample size are necessary for a better understanding of halitosis manifestation in patients wearing provisional and permanent fixed prosthesis.</div>
</front>
</TEI>
<pubmed>
<MedlineCitation Status="MEDLINE" Owner="NLM">
<PMID Version="1">24067465</PMID>
<DateCompleted>
<Year>2014</Year>
<Month>03</Month>
<Day>28</Day>
</DateCompleted>
<DateRevised>
<Year>2017</Year>
<Month>02</Month>
<Day>14</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0394-6320</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>26</Volume>
<Issue>3</Issue>
<PubDate>
<MedlineDate>2013 Jul-Sep</MedlineDate>
</PubDate>
</JournalIssue>
<Title>International journal of immunopathology and pharmacology</Title>
<ISOAbbreviation>Int J Immunopathol Pharmacol</ISOAbbreviation>
</Journal>
<ArticleTitle>Use of Oral Chroma™ in the assessment of volatile sulfur compounds in patients with fixed protheses.</ArticleTitle>
<Pagination>
<MedlinePgn>691-7</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>Prosthetic rehabilitation improves the patient's quality of life and oral health. The purpose of the present study was to assess the production of volatile sulfur compounds (VSCs) using Oral Chroma™ in patients wearing provisional and permanent fixed prosthesis, who were treated or not, with supportive non-surgical periodontal therapy. A total of 10 healthy patients not affected by periodontal disease and who needed the restoration of at least two edentulous single sites were included in the present study. Registrations of VSCs were carried out with a Gas Chromatograph OralChroma™ (Oral Chroma™, Abimedical, Abilit Corp., Osaka, Japan) one month after placement of the provisional restoration (group 1) and one month after placement of the final restoration (group 3). After each measurement, professional oral hygiene was carried out both on patients with provisional (group 2) and permanent prostheses (group 4) and VSC values were registered. The results showed that there were no statistical significant differences in the VSC quantity between groups with temporary or permanent prostheses. Meanwhile, statistically significant differences were found in VCS values between groups before and after the professional health care session (p less than 0.05). Also it was observed that dimethyl sulphide (CH3)2S was present in all the study groups. The present preliminary study suggests that OralChroma™ produce a comprehensive assessment of VSC in the clinical diagnosis of halitosis and that professional oral hygiene seems to influence VSC production. However, further clinical long-term studies with a larger sample size are necessary for a better understanding of halitosis manifestation in patients wearing provisional and permanent fixed prosthesis.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Sinjari</LastName>
<ForeName>B</ForeName>
<Initials>B</Initials>
<AffiliationInfo>
<Affiliation>Department of Medical, Oral and Biotechnological Sciences, University of Chieti-Pescara, Italy.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Murmura</LastName>
<ForeName>G</ForeName>
<Initials>G</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Caputi</LastName>
<ForeName>S</ForeName>
<Initials>S</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Ricci</LastName>
<ForeName>L</ForeName>
<Initials>L</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Varvara</LastName>
<ForeName>G</ForeName>
<Initials>G</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Scarano</LastName>
<ForeName>A</ForeName>
<Initials>A</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D003160">Comparative Study</PublicationType>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>England</Country>
<MedlineTA>Int J Immunopathol Pharmacol</MedlineTA>
<NlmUniqueID>8911335</NlmUniqueID>
<ISSNLinking>0394-6320</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D013457">Sulfur Compounds</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D001419" MajorTopicYN="N">Bacteria</DescriptorName>
<QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D001944" MajorTopicYN="Y">Breath Tests</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D002849" MajorTopicYN="N">Chromatography, Gas</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D003777" MajorTopicYN="N">Dental Prophylaxis</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D003793" MajorTopicYN="N">Dental Restoration, Permanent</DescriptorName>
<QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D003794" MajorTopicYN="N">Dental Restoration, Temporary</DescriptorName>
<QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D006209" MajorTopicYN="N">Halitosis</DescriptorName>
<QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName>
<QualifierName UI="Q000382" MajorTopicYN="N">microbiology</QualifierName>
<QualifierName UI="Q000517" MajorTopicYN="N">prevention & control</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D009910" MajorTopicYN="N">Oral Hygiene</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D011237" MajorTopicYN="N">Predictive Value of Tests</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D016459" MajorTopicYN="N">Prosthesis-Related Infections</DescriptorName>
<QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName>
<QualifierName UI="Q000382" MajorTopicYN="N">microbiology</QualifierName>
<QualifierName UI="Q000517" MajorTopicYN="N">prevention & control</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D013457" MajorTopicYN="N">Sulfur Compounds</DescriptorName>
<QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D014835" MajorTopicYN="N">Volatilization</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="entrez">
<Year>2013</Year>
<Month>9</Month>
<Day>27</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed">
<Year>2013</Year>
<Month>9</Month>
<Day>27</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2014</Year>
<Month>3</Month>
<Day>29</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">24067465</ArticleId>
<ArticleId IdType="pii">12</ArticleId>
<ArticleId IdType="doi">10.1177/039463201302600312</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
<affiliations>
<list>
<country>
<li>Italie</li>
</country>
</list>
<tree>
<noCountry>
<name sortKey="Caputi, S" sort="Caputi, S" uniqKey="Caputi S" first="S" last="Caputi">S. Caputi</name>
<name sortKey="Murmura, G" sort="Murmura, G" uniqKey="Murmura G" first="G" last="Murmura">G. Murmura</name>
<name sortKey="Ricci, L" sort="Ricci, L" uniqKey="Ricci L" first="L" last="Ricci">L. Ricci</name>
<name sortKey="Scarano, A" sort="Scarano, A" uniqKey="Scarano A" first="A" last="Scarano">A. Scarano</name>
<name sortKey="Varvara, G" sort="Varvara, G" uniqKey="Varvara G" first="G" last="Varvara">G. Varvara</name>
</noCountry>
<country name="Italie">
<noRegion>
<name sortKey="Sinjari, B" sort="Sinjari, B" uniqKey="Sinjari B" first="B" last="Sinjari">B. Sinjari</name>
</noRegion>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/EdenteV1/Data/PubMed/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000E01 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd -nk 000E01 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    EdenteV1
   |flux=    PubMed
   |étape=   Checkpoint
   |type=    RBID
   |clé=     pubmed:24067465
   |texte=   Use of Oral Chroma™ in the assessment of volatile sulfur compounds in patients with fixed protheses.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/RBID.i   -Sk "pubmed:24067465" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd   \
       | NlmPubMed2Wicri -a EdenteV1 

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Mon Dec 4 11:02:15 2017. Site generation: Tue Sep 29 19:14:38 2020